Litcius/Paper detail

Predictive factors for the efficacy of abiraterone acetate therapy in high-risk metastatic hormone-sensitive prostate cancer patients

Takashi Ueda, Kazutoshi Fujita, Mitsuhisa Nishimoto, Takumi Shiraishi, Masatsugu Miyashita, Naruhiro Kayukawa, Yuichi Nakamura, Satoshi Sako, Ryota Ogura, Atsuko Fujihara, Takafumi Minami, Fumiya Hongo, Koji Okihara, Kazuhiro Yoshimura, Hirotsugu Uemura, Osamu Ukimura

2022World Journal of Urology14 citationsDOI

Topics & Concepts

Abiraterone acetateMedicineProstate cancerBicalutamideOncologyInternal medicineAndrogen deprivation therapyUrologyCancerAndrogen receptorProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentRadiopharmaceutical Chemistry and Applications
Predictive factors for the efficacy of abiraterone acetate therapy in high-risk metastatic hormone-sensitive prostate cancer patients | Litcius